论文部分内容阅读
目的:分析米索前列醇口服和直肠给药对剖宫产产后出血的治疗效果。方法:选取我院剖宫产产妇96例作为研究对象,以入院先后顺序将患者分为两组,即研究组与对照组各48例;对照组给予单一口服米索前列醇药物治疗,研究组采用米索前列醇直肠给药联合口服方式治疗,并对两组治疗后不良反应、出血量进行对比。结果:研究组治疗后不良反应总数2例少于对照组10例,产后总出血量(200±39.2)ml少于对照组(1449.0±121.0)ml,数据对比差异显著,具有统计学方面的意义(P<0.05)。结论:在剖宫产患者治疗中采用米索前列醇口服联合直肠给药方式治疗,不仅可以降低不良反应的出现,还能减少产后出血量,疗效显著,值得推广。
Objective: To analyze the therapeutic effect of misoprostol oral and rectal administration on cesarean section postpartum hemorrhage. Methods: 96 cases of cesarean section in our hospital were selected as the research object, the patients were divided into two groups according to the order of hospital admission: the study group and the control group, 48 cases each; the control group was given single oral misoprostol drug treatment group Misoprostol rectal administration combined with oral treatment, and two groups of adverse reactions after treatment, the amount of bleeding were compared. Results: The total adverse reaction in study group was less than that in control group (10 cases) and the postpartum total amount of bleeding was (200 ± 39.2) ml less than that in control group (1449.0 ± 121.0) ml, the difference was statistically significant (P <0.05). Conclusion: The treatment of cesarean section patients with misoprostol oral rectal administration, not only can reduce the incidence of adverse reactions, but also reduce the amount of postpartum hemorrhage, the effect is significant, it is worth promoting.